Literature DB >> 28486235

Outcome of Doctors Attending the European Society for Paediatric Endocrinology Winter Schools 2008-2014.

Malcolm D C Donaldson.   

Abstract

BACKGROUND/AIMS: Since 1995, the European Society for Paediatric Endocrinology (ESPE) has hosted Winter School (WS), a 5-day interactive meeting of 25 trainees and 7 teachers designed to cover all main endocrine topics. The aim of the present study was to determine subsequent outcome in ex-WS "students."
METHODS: A questionnaire was sent in August 2016 to all ESPE WS participants between 2008 and 2014. Information was requested on job/training status at WS attendance and in 2016, and subsequent involvement with ESPE.
RESULTS: Of 174 participants (144 women, 30 men) including 5 attending two WS, 129 (74.5%) responded. At the time of WS/2016 survey 58/3 participants were junior trainees, 38/21 senior trainees, and 33/101 consultants. One hundred and seventeen (90.6%) responders were still involved with endocrinology, 107 (82%) rating WS as having a strong/very strong influence on their careers. Following WS, 80/174 (46%) participants had attended at least one ESPE main meeting, 28 (16%) had been awarded ESPE fellowships, and 34 (19%) had become ESPE members.
CONCLUSIONS: The great majority of WS participants responding to the questionnaire are still involved with endocrinology and rated WS as influential. This favourable outcome supports the continuing funding of WS and similar educational programmes.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  European Society for Paediatric Endocrinology; Paediatric endocrinology; Winter School

Mesh:

Year:  2017        PMID: 28486235     DOI: 10.1159/000475596

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  1 in total

1.  Evaluation of DSD training schools organized by cost action BM1303 "DSDnet".

Authors:  R Bertalan; A Lucas-Herald; Z Kolesinska; M Berra; Martine Cools; A Balsamo; O Hiort
Journal:  Orphanet J Rare Dis       Date:  2018-12-18       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.